




Searching News Database: Access Pharmaceuticals
HSMN NewsFeed - 8 Sep 2014
AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors
AMAG Pharmaceuticals Announces Appointment of John A. Fallon, M.D. to Board of Directors
HSMN NewsFeed - 12 Aug 2014
AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer
AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer
HSMN NewsFeed - 7 Jan 2014
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
HSMN NewsFeed - 24 Jun 2013
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
HSMN NewsFeed - 29 Jul 2009
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
HSMN NewsFeed - 27 Jul 2009
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
Access Pharmaceuticals Announces Commercial Launch of MuGard(TM) in Norway by SpePharm
HSMN NewsFeed - 23 Jul 2009
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
MuGard Data From UK Study Shows Prevention of Oral Mucositis in Head and Neck Cancer Patients
HSMN NewsFeed - 20 Apr 2009
SpePharm Announces the European Launches of Two New Products: MuGard and Xerotin
SpePharm Announces the European Launches of Two New Products: MuGard and Xerotin
HSMN NewsFeed - 19 Feb 2009
Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
Access Licenses ProLindac(TM) and MuGard(TM) to JCOM Ltd, an Affiliate of DONG-A Pharmaceuticals in Korea
HSMN NewsFeed - 3 Sep 2008
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
Access Pharmaceuticals Retains Piper Jaffray to Augment Strategic Partnering Efforts
HSMN NewsFeed - 27 Apr 2007
Access Pharmaceuticals Announces Expansion of ProLindac(TM) Clinical Trial Sites
Access Pharmaceuticals Announces Expansion of ProLindac(TM) Clinical Trial Sites
HSMN NewsFeed - 19 Apr 2007
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
HSMN NewsFeed - 21 Feb 2007
Access Pharmaceuticals Signs Letter of Intent to Acquire Somanta Pharmaceuticals
Access Pharmaceuticals Signs Letter of Intent to Acquire Somanta Pharmaceuticals
HSMN NewsFeed - 8 Feb 2007
Access Pharmaceuticals Appoints Esteban Cvitkovic, M.D. as Director and Vice Chairman (Europe)
Access Pharmaceuticals Appoints Esteban Cvitkovic, M.D. as Director and Vice Chairman (Europe)
HSMN NewsFeed - 13 Dec 2006
Access Pharmaceuticals Receives MuGard(TM) Marketing Clearance From the FDA
Access Pharmaceuticals Receives MuGard(TM) Marketing Clearance From the FDA
Additional items found! 15

Members Archive contains
15 additional stories matching:
Access Pharmaceuticals
(Password required)
Access Pharmaceuticals
(Password required)